03:26 AM EDT, 10/21/2025 (MT Newswires) -- John C Reed, Executive Vice President, Innovative Medicine, Research and Development, on October 17, 2025, sold 21,721 shares in Johnson & Johnson ( JNJ ) for $4,185,793. Following the Form 4 filing with the SEC, Reed has control over a total of 10,658 common shares of the company, with 10,658 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml